期刊文献+

不同透析膜对维持性血液透析患者微炎症状态的影响 被引量:7

Effects of different hemodialysis membrane on microinflammatory status in maintenance hemodialysis patients
下载PDF
导出
摘要 目的:探讨不同透析膜对维持性血液透析患者微炎症状态的影响。方法:选取尿毒症透析患者36例,分为F60组(使用高通量聚砜膜透析器F60)和CA130组(使用低通量醋酸纤维素膜透析器CA130),另选取20例健康体检者作为正常对照组,监测治疗前后患者炎症指标水平的变化。结果:与正常对照组比较,治疗前尿毒症患者的血清C-反应蛋白(CRP)、白细胞介素-6(IL-6)水平均显著升高,而白蛋白(ALB)水平显著降低。血液透析治疗8个月后,F60组患者CRP、IL-6水平明显下降,ALB水平明显升高。结论:维持性血液透析患者存在着微炎症状态,高通量合成膜治疗能够显著改善维持性血液透析患者的微炎症状态。 Objective To investigate the effects of different hemodialysis membrane on microinflammatory status in the patients with maintenance hemodialysis, Methods Thrity-six uremic patients were divided into F60 group and CA130 group and another 20 healthy people were taken as normal control group, The concentrations of serum C-reactive protein (CRP) and interleukin-6 (IL-6) were detected, Results Compared with the normal control group, the concentrations of CRP and IL-6 in both F60 group and CA130 group before statin treatment were much higher than those in normal control group, while the concentrations of plasma albumin in both F60 group and CA130 group were significantly lower than that in normal control group, The concentrations of CRP and IL-6 decreased markedly, and the concentrations of plasma albumin increased significantly in F60 group after being treated with hemodialysis therapy for 8 months. Conclusions Microinflammatory status exists in the maintenance hemodialysis patients, The microinflammation in patients with uremia can be inhibited effectively by high flux hemodialysis membrane therapy.
出处 《实用医学杂志》 CAS 2008年第18期3138-3140,共3页 The Journal of Practical Medicine
关键词 尿毒症 肾透析 微炎症 Uremia Renal dialysis Microinflammation
  • 相关文献

参考文献9

  • 1Foley R N, Parfrey P S, Samak M J. Clinical epidemiology of cardiovascular disease in chronic renal disease [J]. Am J Kidney Dis, 1998,32 (Suppl 3 ) : 112-119.
  • 2陈江华,何强,徐莹.维持性血液透析患者微炎症状态的认识与防治[J].中华肾脏病杂志,2005,21(2):117-118. 被引量:146
  • 3Arici M, Walls J. End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link [J]? Kidney Int, 2001,59(2) :407-414.
  • 4Miyata T, Ueda Y, Horie K, et al. Renal catabolism of advanced glycation end products: the fate of pentosidine [J]. Kidney Int, 1998,53(2):416-422.
  • 5康志敏,廖常志,李贵森,王莉,何强.不同透析膜对血透患者血清炎症因子的影响[J].四川医学,2002,23(11):1120-1121. 被引量:3
  • 6Hou F F, Miyata T, Boyce J, et al. beta (2)-Microglobulin modified with advanced glycation end products delays monocyte apoptosis [J]. Kidney Int, 2001,59 ( 3 ) : 990-1002.
  • 7Amore A, Coppo R. Immunological basis of inflammation in dialysis [J]. Nephrol Dial Transplant, 2002,17(Suppl 8) : 16-24.
  • 8Kimmel P L, Phillips T M, Phillips E, et al. Effect of renal replacement therapy on cellular cytokine production in patients with renal disease [ J ]. Kidney Int, 1990,38 ( 1 ) : 129-135.
  • 9Annuk M, Zilmer M, Fellstrom B. Endothelium-dependent vasodilation and oxidative stress in chronic renal failure: impact on cardiovascular disease [J]. Kidney Int Suppl, 2003, (84) :50-53.

二级参考文献2

  • 1张晓洁.高分子合成膜和纤维素膜透析器生物相容性的研究[J].中国实用医学,2001,3(18):42-42.
  • 2解汝娟.血液透析对终末期肾病患者外周血白细胞介素、肿瘤坏死因子α的影响[J].中国血液净化,2001,1:31-31.

共引文献146

同被引文献78

引证文献7

二级引证文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部